IGC PHARMA INC (IGC) Stock Balance Sheet
NYSEARCA:IGC - NYSE Arca - US45408X3089 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2024 (2024-3-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | 2021 (2021-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 1.55M | 1.20M | 3.20M | 10.46M | 14.55M | |||
| Marketable Securities | N/A | 0.00 | 150.00K | 0.00 | 80.00K | |||
| Receivables | 88.00K | 91.00K | 130.00K | 600.00K | 1.92M | |||
| Inventories | 1.51M | 1.54M | 2.65M | 3.55M | 5.48M | |||
| Other Current Assets | 1.11M | 876.00K | 330.00K | 510.00K | 1.50M | |||
| Total Current Assets | 4.25M | 3.71M | 6.47M | 15.11M | 23.52M | |||
| Non-Current Assets | ||||||||
| PPE Net | 3.63M | 3.89M | 8.54M | 9.87M | 11.33M | |||
| Investments And Advances | N/A | N/A | N/A | 0.00 | 10.00K | |||
| Goodwill | N/A | N/A | N/A | N/A | N/A | |||
| Intangibles | 1.80M | 1.62M | 1.17M | 920.00K | 410.00K | |||
| Other Non-Current Assets | 687.00K | 688.00K | 1.00M | 940.00K | 600.00K | |||
| Total Non-Current Assets | 6.12M | 6.20M | 10.71M | 11.72M | 12.35M | |||
| TOTAL ASSETS | 10.37M | 9.90M | 17.18M | 26.83M | 35.87M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 3.00K | 3.00K | 0.00 | 0.00 | 300.00K | |||
| Accrued Expenses | 1.17M | 940.00K | 750.00K | 1.18M | 940.00K | |||
| Accounts Payable | 768.00K | 773.00K | 530.00K | 980.00K | 480.00K | |||
| Other Current Liabilities | 863.00K | 624.00K | 610.00K | 280.00K | 650.00K | |||
| Total Current Liabilities | 2.80M | 2.34M | 1.90M | 2.44M | 2.37M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 135.00K | 137.00K | 140.00K | 140.00K | 280.00K | |||
| Other Non-Current Liabilities | 55.00K | 104.00K | 230.00K | 360.00K | 420.00K | |||
| Total Non-Current Liabilities | 190.00K | 241.00K | 370.00K | 500.00K | 690.00K | |||
| TOTAL LIABILITIES | 2.99M | 2.58M | 2.27M | 2.94M | 3.06M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -117.76M | -113.67M | -100.67M | -89.16M | -74.14M | |||
| Additional Paid In Capital | N/A | N/A | N/A | N/A | N/A | |||
| Minority Interest | N/A | N/A | N/A | N/A | N/A | |||
| Common Shares | 128.58M | 124.41M | 118.97M | 116.02M | 109.72M | |||
| Other Shareholders' Equity | -3.44M | -3.42M | -3.39M | -2.97M | -2.77M | |||
| Shares Outstanding | 76.64M | 66.69M | 53.08M | 51.05M | 47.83M | |||
| Tangible Book Value per Share | 0.07 | 0.09 | 0.26 | 0.45 | 0.68 | |||
| Total Shareholders' Equity | 7.38M | 7.32M | 14.91M | 23.89M | 32.80M | |||
| TOTAL LIABILITIES AND EQUITY | 10.37M | 9.90M | 17.18M | 26.83M | 35.87M | |||
| Statistics | ||||||||
| Debt/Equity | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | |||
| Current Ratio | 1.52 | 1.58 | 3.41 | 6.19 | 9.92 | |||
| Return On Assets (ROA) | -121.22% | -131.29% | -67.00% | -55.98% | -24.56% | |||
| Return On Equity (ROE) | -170.38% | -177.57% | -77.20% | -62.87% | -26.86% | |||
All data in USD , ROIC based on taxRate of 0.21